https://ir.lixte.com/news-events/press-releases/rss en-us https://d1io3yog0oux5.cloudfront.net/_a6aa5996494565f9a411e7ae6a5cce0b/lixte/files/theme/images/logo-sm.png Equisolve Investor Relations Suite https://ir.lixte.com/news-events/press-releases/detail/146/lixte-biotechnology-files-2025-annual-report-on-form-10k-provides-operational-highlights-of-transformative-year Tue, 31 Mar 26 15:45:00 -0400 https://ir.lixte.com/news-events/press-releases/detail/146/lixte-biotechnology-files-2025-annual-report-on-form-10k-provides-operational-highlights-of-transformative-year https://ir.lixte.com/news-events/press-releases/detail/145/lixte-biotechnology-appoints-sidney-braun-as-ceo-of-its-liora-technologies-europe-ltd-subsidiary Wed, 18 Feb 26 08:00:00 -0500 https://ir.lixte.com/news-events/press-releases/detail/145/lixte-biotechnology-appoints-sidney-braun-as-ceo-of-its-liora-technologies-europe-ltd-subsidiary https://ir.lixte.com/news-events/press-releases/detail/144/de-la-soul-led-good-health-summit-launches-february-19-at-morehouse-college Wed, 21 Jan 26 08:00:00 -0500 https://ir.lixte.com/news-events/press-releases/detail/144/de-la-soul-led-good-health-summit-launches-february-19-at-morehouse-college https://ir.lixte.com/news-events/press-releases/detail/143/lixte-biotechnology-attending-the-dealflow-discovery-conference-january-28-29 Tue, 20 Jan 26 08:00:00 -0500 https://ir.lixte.com/news-events/press-releases/detail/143/lixte-biotechnology-attending-the-dealflow-discovery-conference-january-28-29 https://ir.lixte.com/news-events/press-releases/detail/142/lixte-and-its-collaborators-expand-clear-cell-ovarian-cancer-trial Tue, 23 Dec 25 08:00:00 -0500 https://ir.lixte.com/news-events/press-releases/detail/142/lixte-and-its-collaborators-expand-clear-cell-ovarian-cancer-trial https://ir.lixte.com/news-events/press-releases/detail/141/lixte-biotechnology-holdings-inc-announces-4-3-million-registered-direct-offering-priced-at-the-market-under-nasdaq-rules Thu, 18 Dec 25 09:00:00 -0500 https://ir.lixte.com/news-events/press-releases/detail/141/lixte-biotechnology-holdings-inc-announces-4-3-million-registered-direct-offering-priced-at-the-market-under-nasdaq-rules https://ir.lixte.com/news-events/press-releases/detail/140/lixte-biotechnology-acquires-liora-technologies-proprietary-proton-therapy-platform-for-cancer-treatment Tue, 25 Nov 25 08:30:00 -0500 https://ir.lixte.com/news-events/press-releases/detail/140/lixte-biotechnology-acquires-liora-technologies-proprietary-proton-therapy-platform-for-cancer-treatment https://ir.lixte.com/news-events/press-releases/detail/139/lixte-biotechnology-holdings-to-present-at-the-spartan-capital-investor-conference-2025-november-3 Wed, 29 Oct 25 08:00:00 -0400 https://ir.lixte.com/news-events/press-releases/detail/139/lixte-biotechnology-holdings-to-present-at-the-spartan-capital-investor-conference-2025-november-3 https://ir.lixte.com/news-events/press-releases/detail/138/lixte-biotechnology-holdings-highlights-q4-2025-priorities-including-ongoing-advancement-of-lead-candidate-lb-100-strategic-oncology-business-development-and-acquisition-plans Thu, 16 Oct 25 08:00:00 -0400 https://ir.lixte.com/news-events/press-releases/detail/138/lixte-biotechnology-holdings-highlights-q4-2025-priorities-including-ongoing-advancement-of-lead-candidate-lb-100-strategic-oncology-business-development-and-acquisition-plans https://ir.lixte.com/news-events/press-releases/detail/137/lixte-biotechnology-holdings-makes-2-6-million-initial-purchase-of-digital-currency-to-diversify-treasury-and-for-potential-acquisitions Wed, 10 Sep 25 16:05:00 -0400 https://ir.lixte.com/news-events/press-releases/detail/137/lixte-biotechnology-holdings-makes-2-6-million-initial-purchase-of-digital-currency-to-diversify-treasury-and-for-potential-acquisitions